Position in EXEL
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$138,383,836
+$29,658,030 QoQ
Shares Held
2,543,353
+0.3% QoQ
Ownership
1.03%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#23
of 739 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FIRST TRUST ADVISORS LP holds $2,824,813,122 across 97 Biotechnology names. EXEL ranks #5 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
547,132 | $341,158,687 | |
| 2 | INCY |
Incyte Corp
|
1,587,996 | $180,015,226 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
1,829,545 | $159,078,937 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
289,179 | $143,643,884 | |
| 5 | EXEL |
Exelixis, Inc.
This page
|
2,543,353 | $138,383,836 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
421,534 | $126,894,380 | |
| 7 | KRYS |
Krystal Biotech, Inc.
|
324,900 | $120,755,583 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
482,061 | $117,994,070 |
All Filings in EXEL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $138,383,836 | 2,543,353 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $108,725,806 | 2,534,992 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $68,587,287 | 1,564,848 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $59,347,150 | 1,436,977 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $82,435,242 | 1,870,128 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $73,203,056 | 1,982,748 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $84,577,437 | 2,539,863 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $74,440,610 | 2,868,617 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $58,113,418 | 2,586,267 | Shares | Other | 2024-08-13 | |
| 2024-03-31 | $70,563,100 | 2,973,582 | Shares | Other | 2024-05-13 | |
| 2023-12-31 | $75,634,591 | 3,152,755 | Shares | Other | 2024-02-13 | |
| 2023-09-30 | $58,124,102 | 2,660,142 | Shares | Other | 2023-11-13 | |
| 2023-06-30 | $77,512,109 | 4,056,102 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $92,250,566 | 4,752,734 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $61,409,861 | 3,828,545 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $57,173,137 | 3,646,246 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $67,918,837 | 3,262,192 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $80,758,542 | 3,562,353 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $49,844,660 | 2,726,732 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $77,851,834 | 3,682,679 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $57,735,772 | 3,168,813 | Shares | Sole | 2021-10-12 | |
| 2021-03-31 | $79,245,132 | 3,507,974 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $67,217,300 | 3,349,143 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $97,032,343 | 3,968,603 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $102,823,590 | 4,331,238 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $85,534,150 | 4,967,140 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||